Hamzic_2017_Clin.Pharmacol.Ther_102_796

Reference

Title : Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related Toxicity - Hamzic_2017_Clin.Pharmacol.Ther_102_796
Author(s) : Hamzic S , Kummer D , Milesi S , Mueller D , Joerger M , Aebi S , Amstutz U , Largiader CR
Ref : Clinical Pharmacology & Therapeutics , 102 :796 , 2017
Abstract : Hamzic_2017_Clin.Pharmacol.Ther_102_796
ESTHER : Hamzic_2017_Clin.Pharmacol.Ther_102_796
PubMedSearch : Hamzic_2017_Clin.Pharmacol.Ther_102_796
PubMedID: 28139840
Gene_locus related to this paper: human-CES1

Related information

Gene_locus related to this paper: human-CES1

Citations formats

Hamzic S, Kummer D, Milesi S, Mueller D, Joerger M, Aebi S, Amstutz U, Largiader CR (2017)
Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related Toxicity
Clinical Pharmacology & Therapeutics 102 :796

Hamzic S, Kummer D, Milesi S, Mueller D, Joerger M, Aebi S, Amstutz U, Largiader CR (2017)
Clinical Pharmacology & Therapeutics 102 :796